42291-958-30 : NDC 2026 Code

42291-958-30 : Topiramate ( Topiramate )

Additionally :

You can get information about “42291-958-30” NDC code in 42291-958-30 in HTML format

HTML | 42291-958-30 in TXT (Plain Text) format

TXT | 42291-958-30 in PDF (Portable Document Format)

PDF | 42291-958-30 in XML format

XML formats.

NDC Code : 42291-958-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42291-958-30",
    "PackageDescription": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-958-30) ",
    "NDC11Code": "42291-0958-30",
    "ProductNDC": "42291-958",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Topiramate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Topiramate",
    "DosageFormName": "CAPSULE, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20241030",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA206210",
    "LabelerName": "AvKARE",
    "SubstanceName": "TOPIRAMATE",
    "StrengthNumber": "200",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20241030",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}